Omicron Booster Dose
- All
- News
- Videos
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
-
Covaxin Booster Enhances Protection Against Variants Of Concern: ICMR Study
A booster dose of Covaxin administered six months after the two dose primary vaccination has shown elevated immune responses against SARS-CoV-2 variants of concern including Omicron, a study by ICMR and Bharat Biotech has found.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Oil Prices Plunge As Omicron's Rapid Spread Dims Fuel Demand Outlook
Oil prices fell despite Moderna Inc's announcement on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against Omicron in laboratory testing.
-
Australia Approves Covid Vaccine Boosters For 16- And 17-Year-Olds
Australia's drug regulator on Friday approved the use of COVID-19 vaccine booster shots for 16- and 17-year-olds as authorities urge people to get their third doses soon to mitigate the threat from the Omicron coronavirus variant.
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
Covid Vaccine Booster Gives Effective Antibody Protection Against Omicron: Study
A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, according to a study published in The Lancet journal.
-
Booster Dose Neutralises Omicron Variant, Finds Study
An international team of researchers recently studied the sensitivity of Omicron to antibodies compared with the currently dominant Delta variant. The study about this variant has been published in the 'Nature Journal'.
-
Indonesia Launches Booster Jabs To Contain Omicron Spread
Indonesia opened its coronavirus booster campaign to the public Wednesday as the country records rising infections driven by the Omicron variant.
-
WHO's Warning On Repeated Booster Dose Vaccine Strategy For New Variants
WHO experts warned Tuesday that simply repeating booster doses of the original Covid vaccines was not a viable strategy against emerging variants, and called for new jabs that better protect against transmission.
-
Everyone Will Get Omicron, Boosters Won't Stop It: Top Medical Expert
Stressing that Covid is "not a frightening disease anymore" as the new strain is milder and is leading to much less hospitalisation, he said that it's a disease we can deal with.
-
3rd Covaxin Dose Holds Promise: Medical Body Ahead Of Booster Dose Drive
Third dose of Covaxin holds promise, Indian Council of Medical Research said on Sunday just a day before government plans to administer 'precaution' doses of Covid vaccines to frontline, healthcare workers and senior citizens with co-morbidities.
-
Booster Dose Protects Adults Above 65 Against Omicron Infections: UK Study
A third top-up booster dose of a COVID-19 vaccine provides high levels of protection against severe disease from the Omicron variant among older adults, a latest UK study concluded on Saturday.
-
New Registration Not Needed For Covid Vaccine Booster Shot: Centre
There is no need for new registration for those taking the precautionary dose of COVID-19 vaccine and they can directly take an appointment from today or walk-in, the Union Health Ministry said.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
-
Covaxin Booster Enhances Protection Against Variants Of Concern: ICMR Study
A booster dose of Covaxin administered six months after the two dose primary vaccination has shown elevated immune responses against SARS-CoV-2 variants of concern including Omicron, a study by ICMR and Bharat Biotech has found.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Oil Prices Plunge As Omicron's Rapid Spread Dims Fuel Demand Outlook
Oil prices fell despite Moderna Inc's announcement on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against Omicron in laboratory testing.
-
Australia Approves Covid Vaccine Boosters For 16- And 17-Year-Olds
Australia's drug regulator on Friday approved the use of COVID-19 vaccine booster shots for 16- and 17-year-olds as authorities urge people to get their third doses soon to mitigate the threat from the Omicron coronavirus variant.
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
Covid Vaccine Booster Gives Effective Antibody Protection Against Omicron: Study
A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, according to a study published in The Lancet journal.
-
Booster Dose Neutralises Omicron Variant, Finds Study
An international team of researchers recently studied the sensitivity of Omicron to antibodies compared with the currently dominant Delta variant. The study about this variant has been published in the 'Nature Journal'.
-
Indonesia Launches Booster Jabs To Contain Omicron Spread
Indonesia opened its coronavirus booster campaign to the public Wednesday as the country records rising infections driven by the Omicron variant.
-
WHO's Warning On Repeated Booster Dose Vaccine Strategy For New Variants
WHO experts warned Tuesday that simply repeating booster doses of the original Covid vaccines was not a viable strategy against emerging variants, and called for new jabs that better protect against transmission.
-
Everyone Will Get Omicron, Boosters Won't Stop It: Top Medical Expert
Stressing that Covid is "not a frightening disease anymore" as the new strain is milder and is leading to much less hospitalisation, he said that it's a disease we can deal with.
-
3rd Covaxin Dose Holds Promise: Medical Body Ahead Of Booster Dose Drive
Third dose of Covaxin holds promise, Indian Council of Medical Research said on Sunday just a day before government plans to administer 'precaution' doses of Covid vaccines to frontline, healthcare workers and senior citizens with co-morbidities.
-
Booster Dose Protects Adults Above 65 Against Omicron Infections: UK Study
A third top-up booster dose of a COVID-19 vaccine provides high levels of protection against severe disease from the Omicron variant among older adults, a latest UK study concluded on Saturday.
-
New Registration Not Needed For Covid Vaccine Booster Shot: Centre
There is no need for new registration for those taking the precautionary dose of COVID-19 vaccine and they can directly take an appointment from today or walk-in, the Union Health Ministry said.
